发明名称 N-ARYL-N'-ARYLCYCLOALKYL-UREA DERIVATIVES AS MCH ANTAGONISTS FOR THE TREATMENT OF OBESITY
摘要 The present invention discloses compounds of the formula I which, are novel antagonists for melanin−concentrating hormone (MCH), as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such MCH antagonists as well as methods of using them to treat obesity, metabolic disorders, eating disorders such as hyperphagia, and diabetes.
申请公布号 WO03047568(A1) 申请公布日期 2003.06.12
申请号 WO2002US38408 申请日期 2002.12.03
申请人 SCHERING CORPORATION 发明人 CLADER, JOHN, W.;PALANI, ANANDAN;XU, RUO;MC BRIAR, MARK, D.;SU, JING;TANG, HAIQUN
分类号 C07D295/12;A61K31/155;A61K31/17;A61K31/18;A61K31/277;A61K31/381;A61K31/40;A61K31/407;A61K31/4178;A61K31/427;A61K31/44;A61K31/4439;A61K31/444;A61K31/4453;A61K31/4465;A61K31/453;A61K31/4535;A61K31/454;A61K31/495;A61K31/496;A61K31/5375;A61K31/55;A61K31/64;A61K31/7034;A61K38/00;A61K38/28;A61K45/00;A61P3/00;A61P3/04;A61P3/06;A61P3/10;A61P9/12;A61P25/18;A61P25/20;A61P25/22;A61P25/24;C07C275/30;C07D205/04;C07D207/06;C07D207/08;C07D207/10;C07D207/12;C07D207/14;C07D207/27;C07D209/52;C07D211/14;C07D211/22;C07D211/26;C07D211/34;C07D211/38;C07D211/44;C07D211/60;C07D211/70;C07D211/96;C07D213/75;C07D213/89;C07D233/24;C07D233/64;C07D241/04;C07D263/32;C07D295/13;C07D333/36;C07D401/06;C07D401/12;C07D405/04;C07D405/06;C07D409/04;C07D409/06;C07D413/06;C07D413/12;C07D491/048;(IPC1-7):A61K31/40;C07D403/12;C07C275/40;A61K31/440;A61K31/446;A61K31/445 主分类号 C07D295/12
代理机构 代理人
主权项
地址